Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

2DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Oxi-4503 dipotassium, Q9f7qeh36f, Combretastatin a-1 bis(phosphate) dipotassium salt, 1,2-benzenediol, 3-methoxy-6-((1z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-, 1,2-bis(dihydrogen phosphate), potassium salt (1:2), 1014615-46-3, Unii-q9f7qeh36f

Molecular Formula

C₁₈H₂₀K₂O₁₂P₂

Molecular Weight

568.5 g/mol

InChI Key

IQYUGENRXZHYER-XNOMRPDFSA-L

FDA UNII

Q9F7QEH36F

1 2D Structure

Combretastatin A1 Diphosphate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

dipotassium;[2-[hydroxy(oxido)phosphoryl]oxy-3-methoxy-6-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl] hydrogen phosphate

2.1.2 InChI

InChI=1S/C18H22O12P2.2K/c1-25-13-8-7-12(16(29-31(19,20)21)18(13)30-32(22,23)24)6-5-11-9-14(26-2)17(28-4)15(10-11)27-3;;/h5-10H,1-4H3,(H2,19,20,21)(H2,22,23,24);;/q;2*+1/p-2/b6-5-;;

2.1.3 InChI Key

IQYUGENRXZHYER-XNOMRPDFSA-L

2.1.4 Canonical SMILES

COC1=C(C(=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)OP(=O)(O)[O-])OP(=O)(O)[O-].[K+].[K+]

2.1.5 Isomeric SMILES

COC1=C(C(=C(C=C1)/C=C\C2=CC(=C(C(=C2)OC)OC)OC)OP(=O)(O)[O-])OP(=O)(O)[O-].[K+].[K+]

2.2 Other Identifiers

2.2.1 UNII

Q9F7QEH36F

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Oxi-4503 Dipotassium

2. Q9f7qeh36f

3. Combretastatin A-1 Bis(phosphate) Dipotassium Salt

4. 1,2-benzenediol, 3-methoxy-6-((1z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-, 1,2-bis(dihydrogen Phosphate), Potassium Salt (1:2)

5. 1014615-46-3

6. Unii-q9f7qeh36f

7. Q27287150

2.4 Create Date

2010-07-06

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₂₀K₂O₁₂P₂
Molecular Weight	568.5 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	12
Rotatable Bond Count	10
Exact Mass	567.9704130 g/mol
Monoisotopic Mass	567.9704130 g/mol
Topological Polar Surface Area	176 Å²
Heavy Atom Count	34
Formal Charge	0
Complexity	688
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	3